Company intelligence / Profile preview

Jiangsu Sinorda Biomedicine Co., Ltd.

Ownership: Private
Development stage: Commercial

Overview

Jiangsu Sinorda Biomedicine is a Chinese biotech/pharma company focused on innovative drug development for gastrointestinal diseases and oncology immunotherapy. It has three clinical-stage candidates including a Class I new drug potassium competitive acid blocker X842 (NDA accepted), the SLN-T sentinel lymph node T-cell anti-tumor drug in Phase II trials in Europe, and the RIGVIR oncolytic virus drug with IND registration ongoing. The company has established international collaborations and strategic partnerships to accelerate its pipeline.

Therapeutic areas: GastroenterologyOncology
Modalities: Small moleculesBiological products (biologics)Virotherapy/oncolytic virusesTherapeutic vaccinesBispecific antibodies
Industry: Biotech

Drug pipeline

1 asset

SND006

Preclinical

Partnerships

Cinclus Pharma AG – license agreement for linaprazan glurate development/commercialization in AsiaSPH Sine Pharmaceutical Laboratories – sub-licensee of linaprazan glurate manufacturing/sales rights in China/Hong Kong/Macau/TaiwanSanyou Biopharmaceuticals – bispecific antibody co-development partnershipPorton Advanced – strategic collaboration on cell therapy development for solid tumors via subsidiary Jiangsu Tairui Sinorda

Beyond the preview

Go deeper on Jiangsu Sinorda Biomedicine Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiangsu Sinorda Biomedicine Co., Ltd..

Explore the full profile